Cargando…
Decitabine inhibits T cell proliferation via a novel TET2-dependent mechanism and exerts potent protective effect in mouse auto- and allo-immunity models
Multiple sclerosis (MS) is an autoimmune disease characterized by the dysregulated immune response including innate and adaptive immune responses. Increasing evidence has proven the importance of epigenetic modification in the progression of MS. Recent studies revealed that low-dose decitabine (Dec,...
Autores principales: | Wang, Xue, Wang, Jun, Yu, Yong, Ma, Tonghui, Chen, Ping, Zhou, Bing, Tao, Ran |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5593603/ https://www.ncbi.nlm.nih.gov/pubmed/28915632 http://dx.doi.org/10.18632/oncotarget.18063 |
Ejemplares similares
-
Glomerular Macrophages in Human Auto- and Allo-Immune Nephritis
por: Moll, Solange, et al.
Publicado: (2021) -
Myeloma as a Second Malignancy following AML: Is a Second Allo Equivalent to Auto?
por: Bakanay, Sule Mine, et al.
Publicado: (2012) -
Decitabine inhibits the cell growth of cholangiocarcinoma in cultured cell lines and mouse xenografts
por: WANG, BING, et al.
Publicado: (2014) -
Therapeutic effect of bortezomib for primary plasma cell leukemia followed by auto/allo stem cell transplantation
por: Ozasa, Ryotaro, et al.
Publicado: (2012) -
The effect of decitabine-combined minimally myelosuppressive regimen bridged allo-HSCT on the outcomes of pediatric MDS from 10 years’ experience of a single center
por: Gao, Junyan, et al.
Publicado: (2022)